Kohsuke Asagoe

t(14;19)(q32;q13) breakpoints telomeric to BCL3 on 19q13.32 in B-cell lymphomas other than chronic lymphocytic leukemia and long-range structures of der(19)t(14;19) based on optical genome mapping

Hitoshi Ohno, Fumiyo Maekawa, Masahiko Hayashida, Miho Nakagawa et autres

jp (code pays fourni par la source)

Characterization of remdesivir resistance mutations in COVID-19 patients with various immunosuppressive diseases

Takaya Ichikawa, Tomokazu Tamura, Naganori Nao, Hikoyu Suzuki et autres

jp (code pays fourni par la source)

Imaging of cardiac amyloidosis using dynamic 18F-FPYBF-2 positron emission tomography

Chio Okuyama, Yasutaka Inuzuka, Yuzo Takeuchi, Kohsuke Asagoe et autres

jp (code pays fourni par la source)

Analyzing the risk factors for disease progression within 2 years and histological transformation in patients treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone as first‐line treatment: A 15‐year follow‐up of patients with advanced follicular lymphoma in JCOG0203

Takashi Watanabe, Yoshihiro Matsuno, Masashi Wakabayashi, Dai Maruyama et autres

jp (code pays fourni par la source)

Author response for "Analyzing the risk factors for disease progression within 2 years and histological transformation in patients treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone as first‐line treatment: A 15‐year follow‐up of patients with advanced follicular lymphoma in JCOG0203"

Takashi Watanabe, Yoshihiro Matsuno, Masashi Wakabayashi, Dai Maruyama et autres

Methotrexate-induced subacute myelopathy: a serious but treatable complication

Takashi Miyoshi, Tadakazu Kondo, Momoko Nishikori, Katsuya Kobayashi et autres

jp (code pays fourni par la source)

R‐CHOP treatment for patients with advanced follicular lymphoma: Over 15‐year follow‐up of JCOG0203

Takashi Watanabe, Kensei Tobinai, Masaki Wakabayashi, Dai Maruyama et autres

us, jp (code pays fourni par la source)

Clinical characteristics of Japanese patients with myelodysplastic/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis

Yoko Edahiro, Tomonori Ochiai, Yoshinori Hashimoto, Soji Morishita et autres

jp (code pays fourni par la source)

Mild Acute Graft-Versus-Host Disease Improves Outcomes After HLA-Haploidentical-Related Donor Transplantation Using Posttransplant Cyclophosphamide and Cord Blood Transplantation

Fumiya Wada, Junya Kanda, Kimimori Kamijo, Masashi Nishikubo et autres

jp (code pays fourni par la source)

Final Analysis of JCOG0203 for Advanced-Stage Indolent B-Cell Lymphoma 15 Years after the End of Enrollment: Pooled Analysis of Arms a and B for Follicular Lymphoma

Takashi Watanabe, Kensei Tobinai, Masashi Wakabayashi, Dai Maruyama et autres

jp (code pays fourni par la source)

Interim PET-Guided ABVD or ABVD/Escalated BEACOPP for Newly Diagnosed Advanced-Stage Classic Hodgkin Lymphoma (JCOG1305, INNOVATE-HL study)

Shigeru Kusumoto, Wataru Munakata, Ryunosuke Machida, Takashi Terauchi et autres

jp (code pays fourni par la source)

Bortezomib-cyclophosphamide-dexamethasone induction/consolidation and bortezomib maintenance for transplant-eligible newly diagnosed multiple myeloma: phase 2 multicenter trial

Hiroyuki Muranushi, Junya Kanda, Masayuki Kobayashi, Takeshi Maeda et autres

jp (code pays fourni par la source)